Syndromic Multiplex Diagnostics Global Market Report 2025

Description

Syndromic multiplex diagnostics is a molecular testing approach that simultaneously detects and identifies multiple pathogens or biomarkers linked to a particular syndrome from a single patient sample. This approach employs multiplex polymerase chain reaction (PCR) or comparable technologies to provide rapid and comprehensive results. By identifying multiple potential causes at once, these diagnostics support timely and accurate diagnosis of infectious diseases, enhancing clinical decision-making and patient outcomes.

The primary product categories in syndromic multiplex diagnostics include instruments, reagents, software, and services. Syndromic multiplex diagnostic instruments are sophisticated molecular testing systems designed to detect multiple pathogens simultaneously from a single patient sample, using integrated platforms such as real-time polymerase chain reaction (PCR) or microfluidics for fast and precise disease diagnosis. The types of samples analyzed include blood, urine, saliva, and tissue. These diagnostics employ various technologies, including polymerase chain reaction (PCR), mass spectrometry, nucleic acid amplification tests, and next-generation sequencing, and are applied in areas such as infectious diseases, respiratory diseases, gastrointestinal diseases, sexually transmitted infections, and central nervous system diseases. Their end users include clinical laboratories, hospitals, pharmaceutical and biotechnology companies, research institutes, and other organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The syndromic multiplex diagnostics market research report is one of a series of new reports from The Business Research Company that provides syndromic multiplex diagnostics market statistics, including the syndromic multiplex diagnostics industry global market size, regional shares, competitors with the syndromic multiplex diagnostics market share, detailed syndromic multiplex diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the syndromic multiplex diagnostics industry. This syndromic multiplex diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The syndromic multiplex diagnostics market size has grown rapidly in recent years. It will grow from $3.11 billion in 2024 to $3.43 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth observed during the historic period can be attributed to the increasing demand for rapid and precise diagnostics, greater awareness of early disease detection, a rise in hospital-acquired infections, wider adoption of molecular diagnostics, higher healthcare spending, and an expanding need for point-of-care testing.

The syndromic multiplex diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth during the forecast period can be attributed to increasing investments in research and development, greater adoption in low-resource settings, expanding healthcare infrastructure in developing countries, rising government initiatives for infectious disease control, and growing demand for decentralized testing. Key trends in the forecast period include advancements in multiplex polymerase chain reaction (PCR) technologies, innovations in microfluidics and lab-on-chip systems, enhanced automation in sample processing, development of point-of-care molecular platforms, integration of cloud-based diagnostic data systems, and progress in portable diagnostic devices.

The rising prevalence of infectious diseases is anticipated to drive growth in the syndromic multiplex diagnostics market in the coming years. Infectious diseases are caused by harmful microorganisms, including bacteria, viruses, fungi, or parasites, which invade the body, multiply, and cause various symptoms and health complications. The increase in infectious diseases is largely attributed to growing global travel, which facilitates the spread of pathogens across borders and populations. Syndromic multiplex diagnostics support infectious disease management by enabling the rapid and simultaneous detection of multiple pathogens from a single sample. These diagnostics enhance both the speed and accuracy of diagnosis, allowing for timely treatment decisions and improved patient outcomes. For example, in March 2023, the Centers for Disease Control and Prevention, a national public health organization in the United States, reported 8,331 cases of tuberculosis (TB) in 2022, marking a 5.9% rise from 7,874 cases in 2021. Consequently, the growing prevalence of infectious diseases is contributing to the expansion of the syndromic multiplex diagnostics market.

Leading companies in the syndromic multiplex diagnostics sector are concentrating on developing technologically advanced solutions, including AI-powered diagnostic algorithms, to improve the speed, accuracy, and breadth of pathogen detection. AI-enhanced diagnostic algorithms are sophisticated computational tools that use artificial intelligence, particularly machine learning and deep learning methods, to analyze complex clinical and laboratory data for faster and more precise disease diagnosis. For instance, in January 2024, Qiagen N.V., a molecular diagnostics company based in the Netherlands, launched two syndromic testing panels, the Gastrointestinal Panel 2 and the Meningitis and Encephalitis Panel for its QIAstat Dx platform. These panels allow rapid and accurate detection of multiple pathogens in a single test, aiding clinical decision-making and improving patient outcomes. The QIAstat-Dx system also incorporates advanced data analytics, helping healthcare professionals efficiently identify and manage infectious disease outbreaks.

In June 2022, R Biopharm AG, a biotechnology company based in Germany, acquired AusDiagnostics Pty Ltd. for an undisclosed sum. Through this acquisition, R Biopharm aims to expand its product portfolio, enter new clinical diagnostics market segments, and accelerate its international growth strategy, positioning itself as a globally recognized system supplier in laboratory diagnostics across multiple regions. AusDiagnostics Pty Ltd., headquartered in Australia, specializes in in vitro diagnostics (IVD) and syndromic multiplex diagnostics.

Major players in the syndromic multiplex diagnostics market are Roche Molecular Systems Inc., Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Cepheid, Bosch Healthcare Solutions GmbH, Biocartis NV, Luminex Corporation, Curetis GmbH, Accelerate Diagnostics Inc., Applied BioCode Inc., Ador Diagnostics Ltd., Akonni Biosystems Inc., Alveo Technologies Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, Nanomix Inc., Primerdesign Ltd.

North America was the largest region in the syndromic multiplex diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in syndromic multiplex diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the syndromic multiplex diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The syndromic multiplex diagnostics market consists of revenues earned by entities by providing services such as diagnostic workflow integration services, remote testing, clinical decision support tools for syndromic testing, and regulatory and compliance support for diagnostic labs. The market value includes the value of related goods sold by the service provider or included within the service offering. The syndromic multiplex diagnostics market also includes sales of multiplex diagnostic instruments, reagents and consumables, software, and accessories used for the simultaneous detection of multiple pathogens. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Syndromic Multiplex Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on syndromic multiplex diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for syndromic multiplex diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The syndromic multiplex diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Instruments; Reagents; Software And Services
2) By Sample Type: Blood Samples; Urine Samples; Saliva Samples; Tissue Samples
3) By Technology: Polymerase Chain Reaction; Mass Spectrometry; Nucleic Acid Amplification Tests; Next-Generation Sequencing
4) By Application: Infectious Diseases; Respiratory Diseases; Gastrointestinal Diseases; Sexually Transmitted Infections; Central Nervous System Diseases
5) By End User: Clinical Laboratories; Hospitals; Pharmaceutical And Biotechnology Companies; Research Institutes; Other End Users
Subsegments:
1) By Instruments: Real-Time Polymerase Chain Reaction (PCR) Systems; Microfluidic-Based Systems; Automated Sample-To-Answer Systems; Cartridge-Based Systems; Multiplex Polymerase Chain Reaction (PCR) Platforms
2) By Reagents: Assay Panels; Primers And Probes; Enzymes; Buffers And Solutions; Sample Preparation Reagents
3) By Software And Services: Data Analysis Software; Cloud-Based Diagnostic Platforms; Integration And Connectivity Solutions; Technical Support Services; Maintenance And Calibration Services; Training And Installation Services
Companies Mentioned: Roche Molecular Systems Inc.; Abbott Laboratories; Becton Dickinson and Company; Hologic Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Cepheid; Bosch Healthcare Solutions GmbH; Biocartis NV; Luminex Corporation; Curetis GmbH; Accelerate Diagnostics Inc.; Applied BioCode Inc.; Ador Diagnostics Ltd.; Akonni Biosystems Inc.; Alveo Technologies Inc.; Atlas Genetics Ltd.; BioFire Diagnostics LLC; Nanomix Inc.; Primerdesign Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37898

1. Executive Summary

2. Syndromic Multiplex Diagnostics Market Characteristics

3. Syndromic Multiplex Diagnostics Market Trends And Strategies

4. Syndromic Multiplex Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Syndromic Multiplex Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Syndromic Multiplex Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Syndromic Multiplex Diagnostics Market Growth Rate Analysis
5.4. Global Syndromic Multiplex Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Syndromic Multiplex Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Syndromic Multiplex Diagnostics Total Addressable Market (TAM)

6. Syndromic Multiplex Diagnostics Market Segmentation

6.1. Global Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instruments
Reagents
Software And Services
6.2. Global Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Samples
Urine Samples
Saliva Samples
Tissue Samples
6.3. Global Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction
Mass Spectrometry
Nucleic Acid Amplification Tests
Next-Generation Sequencing
6.4. Global Syndromic Multiplex Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Diseases
Respiratory Diseases
Gastrointestinal Diseases
Sexually Transmitted Infections
Central Nervous System Diseases
6.5. Global Syndromic Multiplex Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Laboratories
Hospitals
Pharmaceutical And Biotechnology Companies
Research Institutes
Other End Users
6.6. Global Syndromic Multiplex Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Real-Time Polymerase Chain Reaction (PCR) Systems
Microfluidic-Based Systems
Automated Sample-To-Answer Systems
Cartridge-Based Systems
Multiplex Polymerase Chain Reaction (PCR) Platforms
6.7. Global Syndromic Multiplex Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Assay Panels
Primers And Probes
Enzymes
Buffers And Solutions
Sample Preparation Reagents
6.8. Global Syndromic Multiplex Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Analysis Software
Cloud-Based Diagnostic Platforms
Integration And Connectivity Solutions
Technical Support Services
Maintenance And Calibration Services
Training And Installation Services

7. Syndromic Multiplex Diagnostics Market Regional And Country Analysis

7.1. Global Syndromic Multiplex Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Syndromic Multiplex Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Syndromic Multiplex Diagnostics Market

8.1. Asia-Pacific Syndromic Multiplex Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Syndromic Multiplex Diagnostics Market

9.1. China Syndromic Multiplex Diagnostics Market Overview
9.2. China Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Syndromic Multiplex Diagnostics Market

10.1. India Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Syndromic Multiplex Diagnostics Market

11.1. Japan Syndromic Multiplex Diagnostics Market Overview
11.2. Japan Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Syndromic Multiplex Diagnostics Market

12.1. Australia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Syndromic Multiplex Diagnostics Market

13.1. Indonesia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Syndromic Multiplex Diagnostics Market

14.1. South Korea Syndromic Multiplex Diagnostics Market Overview
14.2. South Korea Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Syndromic Multiplex Diagnostics Market

15.1. Western Europe Syndromic Multiplex Diagnostics Market Overview
15.2. Western Europe Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Syndromic Multiplex Diagnostics Market

16.1. UK Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Syndromic Multiplex Diagnostics Market

17.1. Germany Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Syndromic Multiplex Diagnostics Market

18.1. France Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Syndromic Multiplex Diagnostics Market

19.1. Italy Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Syndromic Multiplex Diagnostics Market

20.1. Spain Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Syndromic Multiplex Diagnostics Market

21.1. Eastern Europe Syndromic Multiplex Diagnostics Market Overview
21.2. Eastern Europe Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Syndromic Multiplex Diagnostics Market

22.1. Russia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Syndromic Multiplex Diagnostics Market

23.1. North America Syndromic Multiplex Diagnostics Market Overview
23.2. North America Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Syndromic Multiplex Diagnostics Market

24.1. USA Syndromic Multiplex Diagnostics Market Overview
24.2. USA Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Syndromic Multiplex Diagnostics Market

25.1. Canada Syndromic Multiplex Diagnostics Market Overview
25.2. Canada Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Syndromic Multiplex Diagnostics Market

26.1. South America Syndromic Multiplex Diagnostics Market Overview
26.2. South America Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Syndromic Multiplex Diagnostics Market

27.1. Brazil Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Syndromic Multiplex Diagnostics Market

28.1. Middle East Syndromic Multiplex Diagnostics Market Overview
28.2. Middle East Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Syndromic Multiplex Diagnostics Market

29.1. Africa Syndromic Multiplex Diagnostics Market Overview
29.2. Africa Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Syndromic Multiplex Diagnostics Market Competitive Landscape And Company Profiles

30.1. Syndromic Multiplex Diagnostics Market Competitive Landscape
30.2. Syndromic Multiplex Diagnostics Market Company Profiles
- 30.2.1. Roche Molecular Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Syndromic Multiplex Diagnostics Market Other Major And Innovative Companies

31.1. Qiagen N.V.
31.2. Cepheid
31.3. Bosch Healthcare Solutions GmbH
31.4. Biocartis NV
31.5. Luminex Corporation
31.6. Curetis GmbH
31.7. Accelerate Diagnostics Inc.
31.8. Applied BioCode Inc.
31.9. Ador Diagnostics Ltd.
31.10. Akonni Biosystems Inc.
31.11. Alveo Technologies Inc.
31.12. Atlas Genetics Ltd.
31.13. BioFire Diagnostics LLC
31.14. Nanomix Inc.
31.15. Primerdesign Ltd.

32. Global Syndromic Multiplex Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Syndromic Multiplex Diagnostics Market

34. Recent Developments In The Syndromic Multiplex Diagnostics Market

35. Syndromic Multiplex Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Syndromic Multiplex Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 Syndromic Multiplex Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 Syndromic Multiplex Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer